IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

January 21st- Microbiota and GVHD: From Unmet Need to a New Therapeutic Paradigm

CME Congresses .

January 21st- Microbiota and GVHD: From Unmet Need to a New Therapeutic Paradigm

January 19th- Luspatercept in Lower-Risk MDS- where do we stand

CME Congresses .

January 19th- Luspatercept in Lower-Risk MDS- where do we stand

January 12th- “Genomically Smoldering” Myeloma Really Smoldering?

CME Congresses .

January 12th- “Genomically Smoldering” Myeloma Really Smoldering?

January 5th- Linvoseltamab in relapsed refractory multiple myeloma: Durable Responses and Real-World Relevance

CME Congresses .

January 5th- Linvoseltamab in relapsed refractory multiple myeloma: Durable Responses and Real-World Relevance

December 31st- Post-Transplant Cyclophosphamide in HLA-Matched Peripheral Blood Transplantation

CME Congresses .

December 31st- Post-Transplant Cyclophosphamide in HLA-Matched Peripheral Blood Transplantation

December 29th- Dr. Richard Dillon and Dr. Jad Othman- Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML

CME Congresses .

December 29th- Dr. Richard Dillon and Dr. Jad Othman- Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML

December 23rd- PRECISION-T: Are We Entering a New Era of GVHD Prophylaxis?

CME Congresses .

December 23rd- PRECISION-T: Are We Entering a New Era of GVHD Prophylaxis?

December 19th- BEYOND the Horizon: Long-Term Luspatercept Data in non–transfusion-dependent β-thalassemia

CME Congresses .

December 19th- BEYOND the Horizon: Long-Term Luspatercept Data in non–transfusion-dependent β-thalassemia

December 18th- ASH 2025 Highlight: Stem Cell Boost for CAR-T–Related Hematologic Toxicity in multiple myeloma: Real-World Evidence

CME Congresses .

December 18th- ASH 2025 Highlight: Stem Cell Boost for CAR-T–Related Hematologic Toxicity in multiple myeloma: Real-World Evidence

December 16th- ASH 2025 Highlight- Menin Inhibitors AML Update

CME Congresses .

December 16th- ASH 2025 Highlight- Menin Inhibitors AML Update